Royalty Pharma
RPRX
#620
Rank
S$50.88 B
Marketcap
S$88.50
Share price
-0.01%
Change (1 day)
72.40%
Change (1 year)

Earnings for Royalty Pharma (RPRX)

Earnings in 2026 (TTM): S$1.98 Billion

According to Royalty Pharma's latest financial reports the company's current earnings are S$2.61 Billion. In 2025 the company made an earning of S$2.10 Billion, an increase over its 2024 earnings that were of S$2.00 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Royalty Pharma from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$1.98 B-5.68%
2025 S$2.10 B4.79%
2024 S$2.00 B-17.54%
2023 S$2.43 B351.47%
2022 S$0.53 B-70.3%
2021 S$1.81 B-24.3%
2020 S$2.39 B-31.9%
2019 S$3.51 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
S$9.30 B 367.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$44.81 B 2,151.45%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$0.20 B-89.78%๐Ÿ‡บ๐Ÿ‡ธ USA